Critical West Nile Neuroinvasive Disease

  • Maximiliano A. Hawkes
  • Ivan D. Carabenciov
  • Eelco F. M. Wijdicks
  • Alejandro A. Rabinstein
Original Article
  • 33 Downloads

Abstract

Background

Data to guide neurointensivists seeing patients with West Nile Neuroinvasive disease (WNND) are lacking. We present a comparatively large series of patients with WNND admitted to the intensive care unit (ICU) and provide data on their early diagnosis, triage to the ICU and predictors of short-term outcomes.

Methods

We retrospectively identified patients aged ≥ 18 years old with WNND from January 1999 to November 2016. Demographic and clinical data, the modified Rankin Scale at discharge and disposition were collected. Univariate analysis was performed to find predictors of ICU admission and to assess the impact of ICU admission on the short-term outcomes. P values < 0.05 were considered significant.

Results

Among 26 patients, 16 were admitted to the ICU. Age < 60 years and the presentation with encephalitis and acute flaccid paralysis predicted ICU admission (P = 0.044 and 0.0007). Among patients requiring ICU admission, four died and no one was discharged home. ICU admission predicted longer hospital stay (P = 0.021), inhospital death (P = 0.034), survival with inability to walk independently (P = 0.0094), and discharge disposition other than home (P = 0.007). In the ICU group, older age was associated with longer hospital stay (P = 0.0001) and inhospital death (P = 0.035).

Conclusion

WNND requiring ICU care has a high morbidity and mortality, especially among older patients. Survivors are highly disabled at discharge, but many improve over time. Therefore, more data on the long-term prognosis of survivors are needed to guide the goals of care in the acute setting.

Keywords

West Nile virus Critical care Encephalitis Acute flaccid paralysis 

Notes

Authors’ Contributions

MAH was involved in study conception, acquisition of data, analysis and interpretation of data, drafting of manuscript and critical revision. IDC contributed to acquisition of data, analysis and interpretation of data, drafting of manuscript and critical revision. EFMW helped in analysis and interpretation of data, drafting of manuscript and critical revision. AAR was involved in study conception, analysis and interpretation of data, drafting of manuscript and critical revision.

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.

References

  1. 1.
    Davis LE, DeBiasi R, Goade DE, Haaland KY, Harrington JA, Harnar JB, et al. West Nile virus neuroinvasive disease. Ann Neurol. 2006;60(3):286–300.CrossRefPubMedGoogle Scholar
  2. 2.
    Prevention CfDCa. West Nile virus disease cases and deaths reported to CDC by year and clinical presentation 1999–2015. https://www.cdc.gov/westnile/statsmaps/cumMapsData.html#three.
  3. 3.
    Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290(4):511–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Bruno A, Akinwuntan AE, Lin C, Close B, Davis K, Baute V, et al. Simplified modified rankin scale questionnaire: reproducibility over the telephone and validation with quality of life. Stroke. 2011;42(8):2276–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Ai J, Xie Z, Liu G, Chen Z, Yang Y, Li Y, et al. Etiology and prognosis of acute viral encephalitis and meningitis in Chinese children: a multicentre prospective study. BMC Infect Dis. 2017;17(1):494.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hart J Jr, Tillman G, Kraut MA, Chiang HS, Strain JF, Li Y, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014;14:248.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Fratkin JD, Leis AA, Stokic DS, Slavinski SA, Geiss RW. Spinal cord neuropathology in human West Nile virus infection. Arch Pathol Lab Med. 2004;128(5):533–7.PubMedGoogle Scholar
  8. 8.
    Nash D, Mostashari F, Fine A, Miller J, O’Leary D, Murray K, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344(24):1807–14.CrossRefPubMedGoogle Scholar
  9. 9.
    Anastasiadou A, Kakoulidis I, Butel D, Kehagia E, Papa A. Follow-up study of Greek patients with West Nile virus neuroinvasive disease. Int J Infect Dis. 2013;17(7):e494–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Klee AL, Maidin B, Edwin B, Poshni I, Mostashari F, Fine A, et al. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis. 2004;10(8):1405–11.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Maximiliano A. Hawkes
    • 1
  • Ivan D. Carabenciov
    • 1
  • Eelco F. M. Wijdicks
    • 1
  • Alejandro A. Rabinstein
    • 1
  1. 1.Division of Critical Care Neurology, Department of NeurologyMayo ClinicRochesterUSA

Personalised recommendations